PFA Compliance Certificate under Reg. 74(5) of SEBI (DP) Regulations, 2018.
Awaiting price reaction for this filing.
Ajanta Pharma submitted a quarterly compliance certificate to BSE and NSE under Regulation 74(5) of the SEBI Depositories Regulations, 2018. The certificate was issued by the company's Registrar and Share Transfer Agent (RTA), MUFG Intime India Private Limited (formerly Link Intime India), for the quarter ended 31st March 2025. The RTA confirmed that all securities received from depository participants for dematerialisation during the quarter were duly processed (accepted or rejected). It also confirmed that the physical share certificates received were mutilated and cancelled after verification, and the depository's name was substituted as the registered owner in the company's register of members within the prescribed timelines.
This is a routine, mandatory quarterly compliance filing with no material impact on the company's financials, operations, or share price. It purely reaffirms that Ajanta Pharma's share dematerialisation process is functioning in line with SEBI regulations.